HealthcareServices

Global Cellular Therapy Tracking Market Report 2026: Emerging Trends and Growth Scenarios

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cellular therapy tracking market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Cellular Therapy Tracking Market reach by 2030 starting from 2026 levels?

The cellular therapy tracking market size has experienced significant growth recently. It is forecast to increase from $2.9 billion in 2025 to $3.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.1%. The expansion observed historically is due to factors such as increasing clinical trial activity for cell therapies, rising regulatory scrutiny on advanced therapies, growth in personalized medicine programs, early adoption of digital tracking systems, and the expansion of biologics manufacturing.

The cellular therapy tracking market is projected to experience substantial expansion in the coming years. It is expected to achieve a market size of $5.31 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.8%. This anticipated growth is driven by factors such as the increasing commercialization of cell and gene therapies, a rising need for real-time visibility into treatments, the expansion of decentralized clinical trials, a heightened focus on ensuring patient safety and compliance, and increased investment in digital health infrastructure. Noteworthy trends during this forecast period involve the growing adoption of end-to-end platforms for therapy traceability, the enhanced integration of compliance and reporting software, an uptick in the utilization of real-time supply chain monitoring, the development of data-driven tools for workflow optimization, and a stronger emphasis on regulatory transparency.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28162&type=smp

Which Drivers Are Influencing Long-Term Growth In The Cellular Therapy Tracking Market?

The expanding integration of personalized medicine is anticipated to fuel the expansion of the cellular therapy tracking market in the future. This medical approach involves customizing treatment and prevention strategies based on a person’s distinct genetic profile, lifestyle choices, and environmental factors. The rising acceptance of personalized medicine largely stems from progress in genomics, allowing for the accurate detection of genetic variations and the creation of bespoke treatments for patients. Cellular therapy tracking plays a crucial role in personalized medicine by guaranteeing precise oversight and control of cells specific to each patient throughout their therapeutic journey. This system boosts the safety and effectiveness of treatments through complete traceability, adherence to regulations, and optimized operational procedures for healthcare professionals. For example, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that the U.S. Food and Drug Administration (FDA) authorized 26 new personalized medicines in 2023, which represents a notable rise from the 12 approved in 2022. Consequently, the growing embrace of personalized medicine is propelling the expansion of the cellular therapy tracking market.

Which Segments Are Driving Activity In The Cellular Therapy Tracking Market?

The cellular therapy tracking market covered in this report is segmented –

1) By Product Type: Software, Services

2) By Application: Cancer, Cardiovascular Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications

3) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users

Subsegments:

1) By Software: Patient Registry Software, Clinical Trial Management Software, Electronic Data Capture (EDC) Systems, Laboratory Information Management Systems (LIMS), Cell Therapy Supply Chain Management Software, Compliance And Reporting Software, Data Analytics And Visualization Tools

2) By Services: Implementation And Integration Services, Training And Education Services, Consulting Services, Managed Services, Technical Support And Maintenance, Data Security And Compliance Services

Which Trends Are Influencing The Development Of The Cellular Therapy Tracking Market?

Leading companies active in the cellular therapy tracking market are prioritizing the development of adaptable platforms, such as chain of identity (COI) management platforms, to guarantee cell traceability, adherence to regulations, and patient safety. Chain of identity (COI) management platforms are defined as digital systems that monitor and verify the identification of patient-specific cells throughout the entire cellular therapy procedure, thus ensuring traceability and patient safety. For instance, in May 2023, TrakCel Limited, a UK-based software company, unveiled OCELLOS Core, a new product within its OCELLOS suite, designed as a Chain of Identity (COI) management platform for early-stage autologous and personalized cell and gene therapy (CGT) clinical trials. This platform offers automated COI tracking, ensuring accurate patient records from the initial enrollment. The pre-configured, validated system can be put into operation within 2–3 weeks, providing cost-effective scalability as therapies advance from trials to commercialization. It also records chain of custody events with complete audit trails, boosting compliance and cooperation.

Which Major Firms Are Strengthening Their Position In The Cellular Therapy Tracking Market?

Major companies operating in the cellular therapy tracking market are Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Gilead Sciences Inc., Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Lonza Group Ltd., Nikon Corporation, Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Vericel Corporation, Adaptimmune Therapeutics plc, Medipost Co. Ltd., TrakCel

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cellular-therapy-tracking-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Cellular Therapy Tracking Market?

North America was the largest region in the cellular therapy tracking market in 2025. The regions covered in the cellular therapy tracking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cellular Therapy Tracking Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28162&type=smp

Browse Through More Reports Similar to the Global Cellular Therapy Tracking Market 2026, By The Business Research Company

Cell Viability Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Therapeutic Drug Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795